/
/

Sonia Garcia

Co-Founder & Chief Growth Officer

LinkedIn

Sonia Garcia is the co-founder and Chief Growth Officer of Amae Health. Her mission is deeply personal—after losing her father to suicide at 16 and supporting her brother through his journey with schizoaffective disorder, Sonia has dedicated her life to transforming the mental health system with compassion, innovation, and urgency. A Knight-Hennessy Scholar with an M.S. in Engineering Design Impact from Stanford University’s d.school, Sonia’s expertise lies at the intersection of human-centered design and mental healthcare innovation. Her thesis explored new models of care delivery, a vision she has since brought to life. Before launching Amae Health, she was instrumental in scaling Brightline, the nation’s first digital pediatric behavioral health company. Sonia’s leadership and impact have earned her national recognition, including being named to Inc.’s Female Founders 2025 and Business Insider’s 30 Under 40 in Healthcare. She continues to be a driving force in behavioral health, advocating for accessible, high-quality care that meets people where they are.

Academic Background

Professional Certifications

Recognitions and Scholarly Work

Memberships and Affiliations

Perspectives from Sonia

# min read

TMS vs Ketamine and Spravato for Treatment-Resistant Depression

By

Sonia Garcia

|

October 5, 2026

f you are comparing TMS, ketamine, and Spravato for depression, you have probably reached the point where standard antidepressants have not done enough. All three are evidence-based options for treatment-resistant depression, and beyond that they have little in common. TMS is a course of magnetic stimulation delivered while you sit awake in a chair. Ketamine is an anesthetic given by IV, used off-label for depression. Spravato is a nasal spray made from esketamine, one of the two mirror-image forms that make up ketamine, with its own FDA approval and its own rulebook.

‍

None of the three is universally better. They differ in mechanism, speed, setting, and monitoring, and the right one depends on your clinical history and how you respond. Treatment-resistant depression generally means depression that has not adequately improved after at least two antidepressants taken at a proper dose for long enough, and that is the group where all three are most often used.

What Is TMS?

Transcranial magnetic stimulation uses a coil placed against the scalp to deliver focused magnetic pulses to the left dorsolateral prefrontal cortex, a region involved in mood regulation. The FDA first cleared TMS for major depressive disorder in 2008, according to the National Institute of Mental Health. It is delivered in an office, with no anesthesia and no medication.

‍

Our standard TMS course runs 20 to 30 daily sessions over four to six weeks, each 30 to 40 minutes long. You stay awake throughout and drive yourself home afterward. In real-world outcome data from 42 U.S. practices, more than half of patients with medication-resistant depression responded to a standard course, and more than a third reached remission.

What Is Ketamine Therapy?

Ketamine has been an FDA-approved anesthetic since 1970. Its use for depression is off-label: prescribed for a purpose the FDA has not formally approved, which is legal and common in medicine but leaves the safeguards less standardized. It is usually given as an IV infusion in a monitored clinic, as a series of sessions over a few weeks.

‍

Ketamine blocks the NMDA receptor, a glutamate receptor, rather than acting on serotonin like standard antidepressants, and that difference is thought to explain its speed. In a landmark 2006 trial, 18 people with treatment-resistant depression received a single infusion of 0.5 mg/kg, and their symptoms improved significantly within 110 minutes. By the next day, 71% had responded and 29% were in remission. One week later, 35% still met the response threshold. Rapid, real, and often short-lived.

‍

The catch is in the monitoring. Ketamine causes dissociation, a sense of detachment from your body or surroundings, plus sedation and blood pressure rises during and after the infusion, so you are observed until those effects pass and cannot drive that day. In a 2017 consensus statement in JAMA Psychiatry, an American Psychiatric Association task force found the evidence for rapid antidepressant effects convincing but the studies small, the longer-term efficacy data lacking, and the safety data on repeated dosing limited.

What Is Spravato (Esketamine)?

Ketamine is a mixture of two mirror-image molecules. Spravato is esketamine, one of those two, delivered as a nasal spray. Unlike IV ketamine, it has FDA approval for depression. The original approval came in March 2019 for treatment-resistant depression alongside an oral antidepressant, a second indication followed for adults with major depressive disorder and acute suicidal thoughts or behavior, and in January 2025 the FDA approved Spravato as a standalone monotherapy for treatment-resistant depression, with no oral antidepressant required, per the current prescribing information.

‍

That approval comes with a rulebook. Spravato can only be given at a setting certified under a Risk Evaluation and Mitigation Strategy (REMS) program: you take the spray under supervision, you are monitored for at least two hours before an assessment clears you to leave, and you cannot drive until the next day after a restful sleep. Its label carries a boxed warning for sedation, dissociation, respiratory depression, abuse and misuse, and suicidal thoughts and behaviors in younger patients.

‍

So is Spravato the same as ketamine? Related, not identical: same molecular family, same receptor, similar rapid onset and dissociative effects, but a different route, a formal FDA indication, and mandatory monitoring rules that off-label ketamine does not carry. For most people comparing TMS vs Spravato, those rules and insurance coverage are the practical differences that matter.

TMS vs Ketamine vs Spravato: Side-by-Side Comparison

Feature TMS IV ketamine Spravato (esketamine)
Mechanism Magnetic pulses stimulate the prefrontal cortex NMDA receptor antagonist, given intravenously NMDA receptor antagonist, nasal spray
FDA status Cleared for MDD (2008) and OCD (2018) Approved as an anesthetic; off-label for depression Approved for TRD (2019 with an oral antidepressant; 2025 as monotherapy) and for MDD with acute suicidal ideation
Onset Gradual, across a multi-week course Hours to days Hours to days
Session format 30 to 40 minutes, awake, in an office Infusion in a monitored clinic Self-administered spray under supervision in a certified setting
Monitoring None after the session Observed during and after the infusion At least two hours after each dose
Driving Drive yourself home Not that day Not until the next day
Typical course 20 to 30 daily sessions over 4 to 6 weeks A series of infusions over several weeks, then maintenance as needed Twice a week for the first four weeks, then weekly, with later dosing individualized
Common side effects Scalp discomfort, headache Dissociation, sedation, blood pressure rise, nausea Dissociation, dizziness, nausea, sedation, vertigo, raised blood pressure

Onset and Duration of Effect

Speed is the clearest dividing line. TMS builds gradually, and many people do not notice a clear change until the second or third week or later. Ketamine and Spravato can shift symptoms within hours to days.

‍

Speed and staying power are different things. Ketamine's effect after a single infusion often fades within a week or two, which is why it is given as a series with maintenance dosing. Spravato starts at twice a week and tapers, with the need for continued treatment reassessed along the way. Research on durability is still developing for all three, and none should be described as permanent.

Side Effects and Safety Considerations

TMS side effects are local and short-lived: scalp discomfort where the coil sits, headache, and sometimes brief lightheadedness or facial muscle twitching during the pulses. These usually settle within the first week, and because nothing enters the bloodstream there is no weight gain, sexual dysfunction, or sedation. Seizure is the one serious risk, exceedingly rare, and TMS is not used in people with a seizure history, metal in the head, or implanted electronic devices.

‍

Ketamine and Spravato share a different profile. The most common reactions to Spravato in trials were dissociation, dizziness, nausea, sedation, vertigo, numbness, anxiety, lethargy, increased blood pressure, vomiting, feeling drunk, and headache. Those effects peak in the hours after dosing, which is what the monitoring window is for, and both drugs carry a potential for misuse that shapes who is a candidate. Each option has its own screening, and a contraindication to one does not rule out the others.

Cost and Insurance

For TMS, most commercial insurers cover treatment for major depressive disorder once eligibility criteria are met, typically a confirmed diagnosis and documented antidepressant trials without adequate relief. Prior authorization is standard. For TMS we take all commercial insurance plans, cash pay is available, and authorization is something our intake team manages for you.

‍

Spravato is more commonly covered than off-label ketamine because it has an FDA indication insurers can write criteria around, though prior authorization and documentation of failed antidepressant trials are typically required. Ketamine infusion coverage varies widely, and many clinics are self-pay. Published cost estimates vary so much by dose, frequency, and insurance status that a single dollar figure would mislead; ask each provider and your insurer directly.

Can These Treatments Be Combined?

Sometimes, and the research is early. A 2024 systematic review found six published studies on combining TMS with ketamine, mostly case reports plus one retrospective review and one small pilot, and reported substantial and sustained improvement with generally mild side effects. The authors also said the designs were too varied and the samples too small for firm conclusions, and called for randomized trials.

‍

In practice, TMS and Spravato are sometimes used one after the other. Combining any of these is a clinical judgment a psychiatrist makes from your history, not a general recommendation, and the more common pattern is to use one, assess the response, then decide.

Choosing Between Them: What Influences the Decision

A psychiatrist weighing these options usually works through a short list:

‍

  • Treatment history. Which antidepressants, at what doses, for how long, and whether psychotherapy has been tried.
  • How urgently relief is needed. When symptoms are severe or suicidal thoughts are present, a faster-acting option may take priority, alongside care for suicidal thoughts.
  • Tolerance for the experience. Dissociation and a two-hour monitored window, versus a daily half-hour appointment for several weeks with no drug effects.
  • Practical constraints. Whether you can get to daily sessions, whether someone can drive you home after Spravato or ketamine, and what your insurance will authorize.
  • Health factors. Seizure history, metal implants, blood pressure, and any history of substance misuse each rule options in or out.
  • What else is in place. Any of the three works better inside ongoing psychiatric care and therapy than as a standalone fix.

Making the Decision With an Integrated Care Team

TMS, ketamine, and Spravato are tools, and tools do their best work inside a plan: a psychiatrist who knows your history, a therapist working alongside the biological treatment, and a team that notices when the plan needs to change.

‍

That is how we work. At Amae, our one-team care model combines psychiatry, therapy, primary care, and peer support, and TMS and Spravato are available through our Los Angeles and Bay Area clinics as part of that care. If you have been through the antidepressant cycle and want a clear, unhurried look at what comes next, talk with an Amae psychiatrist about your options. If you are in crisis or thinking about suicide, call or text 988 now.

Frequently Asked Questions

What is the difference between TMS and ketamine for depression?

TMS stimulates the brain with magnetic pulses over a course of daily outpatient sessions, with no drug, no sedation, and no monitoring afterward. Ketamine is a medication that acts on NMDA receptors, given by infusion or, as esketamine, by nasal spray, with monitored sedation and dissociation and often faster but shorter-lived effects.

Is Spravato the same as ketamine?

Related but not identical. Spravato is esketamine, the S-enantiomer of the ketamine molecule, delivered as an FDA-approved nasal spray under a required monitoring program. Ketamine infusions use the full ketamine compound and are prescribed off-label for depression, without an FDA indication for that use.

Is Spravato only approved with an antidepressant?

Not anymore. The original 2019 approval was for use alongside an oral antidepressant, and in January 2025 the FDA also approved Spravato as a standalone monotherapy for adults with treatment-resistant depression. Whether it is used alone or with an antidepressant is a decision your psychiatrist makes based on your situation.

Which works faster, TMS or Spravato?

Spravato. Esketamine and ketamine can produce symptom change within hours to days, while TMS builds gradually across a four-to-six-week course. Faster onset does not mean more durable improvement, and both durability and side effects belong in the comparison.

Can TMS and Spravato be used together?

Sometimes, as a clinical decision made with a psychiatrist based on your individual history. Both can be part of a broader treatment-resistant depression plan alongside medication and therapy, and the evidence on combining them is still early.

Is ketamine or Spravato covered by insurance?

Spravato is more commonly covered, because it has an FDA indication insurers can build criteria around, though prior authorization and proof of failed antidepressant trials are usually required. Coverage for off-label ketamine infusions varies widely and is often self-pay. Confirm with the provider and your insurer before starting.

‍

Citations

  1. National Institute of Mental Health. Brain Stimulation Therapies. https://www.nimh.nih.gov/health/topics/brain-stimulation-therapies/brain-stimulation-therapies (Tier 2)
  2. Carpenter LL, Janicak PG, Aaronson ST, et al. Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of acute treatment outcomes in clinical practice. Depression and Anxiety. 2012. https://pubmed.ncbi.nlm.nih.gov/22689344/ (Tier 1)
  3. Zarate CA, Singh JB, Carlson PJ, et al. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Archives of General Psychiatry. 2006. https://pubmed.ncbi.nlm.nih.gov/16894061/ (Tier 1)
  4. Sanacora G, Frye MA, McDonald W, et al. A consensus statement on the use of ketamine in the treatment of mood disorders. JAMA Psychiatry. 2017. https://pubmed.ncbi.nlm.nih.gov/28249076/ (Tier 1)
  5. U.S. Food and Drug Administration. Drugs@FDA: SPRAVATO (esketamine), NDA 211243, approval history. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211243 (Tier 2)
  6. U.S. Food and Drug Administration. SPRAVATO (esketamine) nasal spray prescribing information, revised January 2025. https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/211243s016lbl.pdf (Tier 2)
  7. Arubuolawe OO, Folorunsho IL, Busari AK, et al. Combination of transcranial magnetic stimulation and ketamine in treatment-resistant depression: a systematic review. Cureus. 2024. https://pubmed.ncbi.nlm.nih.gov/39156335/ (Tier 1, small-study review)
  8. 988 Suicide and Crisis Lifeline. https://988lifeline.org (Tier 2)

‍

# min read

Best Mental Health Clinics in Raleigh, NC

By

Sonia Garcia

|

September 30, 2026

Mental health care in Raleigh has expanded significantly in recent years, but more options doesn’t make the choice easier, it makes clarity about what you need more important. The right clinic depends on your diagnosis, how much support you need, and what your insurance covers.

Mental health care in Raleigh, NC ranges from large multi-location networks to academic medical centers to small telehealth practices, and the right choice depends on what you are actually dealing with. Someone looking for weekly therapy for anxiety needs something very different from someone stabilizing a first psychotic episode, and the Triangle has clinics built for each. This guide organizes the area’s leading clinics by what they do, then covers provider types, conditions, telehealth, insurance, and the practical steps to get started.

What to Look for in a Mental Health Clinic in Raleigh

A few factors separate a good fit from the wrong one:

–  Evidence-based treatment. Look for established approaches: CBT, DBT, and medication management, backed by clinicians trained to deliver them.

–  Team composition. Behavioral health in Raleigh, NC is delivered by different provider types: psychiatrists, therapists (LCSW, LCMHC), nurse practitioners, and peer support. Integrated clinics coordinate them under one team.

–  Conditions treated. Some clinics handle complex or co-occurring conditions; others focus on general anxiety and depression. Match the clinic to your diagnosis.

–  Insurance. Confirm in-network status with your plan, whether that is Blue Cross Blue Shield of North Carolina, Aetna, Cigna, NC Medicaid, or Alliance Health. The same visit can cost very differently depending on your coverage.

–  In-person vs. telehealth. Most Raleigh clinics now offer both; decide which suits you before booking.

–  Wait times. New-patient availability ranges from same-week to months out, especially at academic centers. Ask before you commit, because a shorter path to care matters when symptoms are acute.

Best Mental Health Clinics in Raleigh, NC

Raleigh’s clinics fall into distinct categories, each built for a different need: integrated care for serious mental illness, large outpatient networks, therapy-focused practices, integrated substance-use and primary care, telehealth psychiatry, and academic medical centers. The best clinic is the one whose category fits your situation, so the providers below are grouped that way rather than ranked against each other.

Details were verified from each provider as of 2026; confirm current specifics directly, since programs and insurance networks change.

Amae Health: Integrated Care for Adult Complex Mental Illness

At our Raleigh clinic at 4000 Wake Forest Road, Suite 200, Amae Health provides integrated outpatient care for adults living with severe and complex mental illness, delivered in collaboration with leading academic medical centers including NewYork-Presbyterian, Cedars-Sinai, and Mass General Brigham. We treat schizophrenia, schizoaffective disorder, first-episode psychosis, major depressive disorder, bipolar disorder, suicidal thoughts, and co-occurring conditions.

The difference is the team, not any single service. Every patient works with a coordinated group under one roof: psychiatrists for medication management, therapists delivering integrated CBT and DBT, group therapy, peer support specialists, health coaches, and a registered dietitian focused on nutrition, exercise, and sleep. That structure is built for conditions that need more than a single weekly appointment can offer.

–  Specialties: Schizophrenia, first-episode psychosis, schizoaffective disorder, major depressive disorder, bipolar disorder, suicidal thoughts, co-occurring conditions

–  Care model: Integrated psychiatry, CBT and DBT therapy, group therapy, peer support, and health coaching

–  Insurance: Blue Cross Blue Shield of North Carolina, Aetna, Cigna/Evernorth, and Alliance Medicaid; same-day appointments available

–  Phone: (984) 849-4342

–  Best for: Adults with serious or complex mental illness who want fully integrated, psychiatrist-led care

Mindpath Health: Large Multi-Location Outpatient Network

Mindpath Health is a large outpatient mental health provider with locations across the Triangle and North Carolina, including Raleigh. It offers psychiatry, therapy, medication management, and telehealth for adults, children, and adolescents, plus interventional options like TMS and Spravato through a dedicated department. Its scale translates to broad availability across conditions and locations, often with shorter waits for a first appointment.

–  Specialties: Depression, anxiety, ADHD, bipolar disorder, PTSD, OCD, and more, across all ages

–  Care model: Multi-location outpatient network, in-person and telehealth

–  Best for: People who want broad access, multiple locations, and interventional psychiatry options

Ellie Mental Health: Therapy-Focused Outpatient Care

Ellie Mental Health’s Raleigh clinic at 2709 Blue Ridge Road, Suite 190, is a therapy-first practice. Its team of licensed therapists and counselors provides individual, couples, family, and trauma-informed therapy, in person and online, with extended weekday and Saturday hours. This is talk therapy rather than intensive psychiatric programming.

–  Specialties: Anxiety, depression, life transitions, trauma, and mood concerns

–  Care model: Outpatient individual, couples, and family therapy

–  Insurance: In-network with most major plans including Medicaid, plus sliding-scale fees

–  Best for: People seeking talk therapy in a flexible, therapy-focused setting

The Carter Clinic: Integrated Substance Use and Primary Care

The Carter Clinic is a North Carolina practice with multiple locations, including Raleigh, that combines mental health, substance use recovery, and primary care. It provides dual-diagnosis treatment for co-occurring conditions, medication-assisted treatment for opioid use disorder, and intensive outpatient options, alongside routine primary care.

–  Specialties: Co-occurring mental health and substance use, primary care

–  Care model: Integrated behavioral health, addiction recovery, and primary care, in person and telehealth

–  Insurance: Accepts most plans, including Medicaid and Medicare, with sliding-scale fees

–  Best for: People managing substance use alongside a mental health condition

Apogee Behavioral Medicine: General Outpatient Psychiatry and Therapy

Apogee Behavioral Medicine’s Raleigh clinic at 7200 Creedmoor Road, Suite 200, offers psychiatry and counseling in person and via telehealth. Services include psychiatric evaluations, medication management, CBT, and psychodynamic therapy for anxiety, mood disorders, ADHD, and depression.

–  Specialties: Anxiety, depression, ADHD, OCD, PTSD, bipolar disorder

–  Care model: Outpatient psychiatry and therapy, in-person and telehealth

–  Insurance: Accepts most major plans, plus Medicare and Medicaid

–  Best for: Adults seeking general outpatient psychiatry and therapy in North Raleigh

Raleigh Wellness & Behavioral Health: Telehealth Psychiatry

Raleigh Wellness & Behavioral Health is a virtual-only outpatient psychiatry practice serving patients across North Carolina. Its team of physician assistants and nurse practitioners provides psychiatric evaluations and medication management for depression, anxiety, bipolar disorder, ADHD, PTSD, and OCD, with some same-week availability for new patients.

–  Specialties: Depression, anxiety, bipolar disorder, ADHD, PTSD, OCD

–  Care model: Telehealth-only psychiatric evaluation and medication management

–  Best for: Adults who want convenient, medication-focused psychiatric care by telehealth

Duke Health Psychiatry: Academic Medical Center

Duke Health provides academic psychiatric care across the Raleigh-Durham area, including Duke Behavioral Health North Durham, which brings outpatient, inpatient, and ECT services together in one building. Duke offers psychiatric consultation, medication management, individual and group psychotherapy, and brain stimulation options, in person and by telehealth, with the subspecialty depth of an academic medical center. As with most academic centers, the tradeoff is that intake can take longer than at a private practice.

–  Specialties: Complex and treatment-resistant presentations across the full range of conditions

–  Care model: Academic medical center, outpatient and telehealth

–  Best for: Patients with complex or treatment-resistant conditions who want academic-center care

Types of Behavioral Health Providers in Raleigh, NC

Different provider types offer different services. Knowing the difference helps you find the right fit faster.

Psychiatrists

Psychiatrists are medical doctors who diagnose mental health conditions, prescribe and manage medication, and sometimes provide therapy. Psychiatry in Raleigh, NC does not require a referral, and psychiatrists are the right starting point when medication management is central to treatment.

Therapists and Counselors (LCSW, LCMHC)

Therapists provide talk therapy, including CBT, DBT, and trauma-informed approaches, but cannot prescribe medication. They are the most common outpatient providers in Raleigh. Many people see both a therapist and a psychiatrist, or a clinic that coordinates both.

Psychiatric Nurse Practitioners and Physician Assistants (PMHNP, PA-C)

Psychiatric nurse practitioners and physician assistants can diagnose and prescribe in North Carolina. They are common across Raleigh outpatient and telehealth practices and often work alongside psychiatrists in integrated care teams.

Conditions Treated at Mental Health Clinics in Raleigh

Most outpatient clinics treat a range of conditions, though some specialize:

–  Depression and treatment-resistant depression. A depression treatment center in Raleigh with interventional options like TMS or Spravato can help when standard antidepressants have not worked.

–  Anxiety disorders, including generalized anxiety, panic disorder, social anxiety, and OCD.

–  Bipolar disorder. Best managed at integrated clinics with coordinated psychiatry and therapy.

–  ADHD. Assessment and medication management are widely available across Raleigh clinics.

–  PTSD and trauma. Look for trauma-informed therapy or clinicians trained in CPT or EMDR.

–  Schizophrenia, schizoaffective disorder, and first-episode psychosis. These benefit from specialized, structured psychiatric support.

–  Co-occurring substance use and mental health conditions, best treated together by an integrated team.

In-Person vs. Telehealth Mental Health Care in Raleigh

Most Raleigh clinics now offer both in-person and telehealth care, and the right choice depends on the situation. Telehealth works well for ongoing medication management and continuing therapy, and it removes the barriers of travel and scheduling, which matters in a spread-out metro like the Triangle. In-person care is often preferable for an initial psychiatric evaluation, for complex conditions, or when hands-on support matters, because a clinician can pick up on cues that are harder to read over video. NC Medicaid and most commercial insurers cover telehealth mental health visits, so cost is rarely the deciding factor. Many people use a mix: an in-person evaluation to start, then telehealth for follow-up once a relationship is established.

Insurance and Cost for Mental Health Treatment in Raleigh, NC

Most Raleigh clinics accept major commercial plans, including Blue Cross Blue Shield of North Carolina, Aetna, and Cigna/Evernorth, along with NC Medicaid managed-care plans like Alliance Health and Healthy Blue. Under the federal Mental Health Parity and Addiction Equity Act, plans that cover mental health must apply financial terms no more restrictive than those for medical care (CMS, MHPAEA).

Without insurance, therapy sessions in Raleigh typically run $100 to $200 per visit and psychiatry $200 to $400, as general ranges rather than quotes. Some practices offer sliding-scale fees based on income.

If you go out of network, ask the provider for a superbill, a detailed receipt you can submit to your insurer for partial reimbursement. Our patients and families resources can help you prepare, and you should confirm every figure with the clinic and your insurer before starting.

How to Find the Right Mental Health Clinic in Raleigh

A practical sequence:

1.  Identify what you need. Medication, therapy, or both? Your symptoms and daily functioning point to the level of care.

2.  Check insurance before booking. Confirm in-network status and your copay.

3.  Search by location, condition, and insurance. The Psychology Today therapist directory and SAMHSA’s FindTreatment.gov locator both filter on all three.

4.  Verify the provider’s license. You can confirm a clinician is licensed and in good standing through the North Carolina Medical Board or the NC Psychology Board.

5.  Ask about new-patient availability and telehealth. A shorter path to care matters when symptoms are acute.

If you want help thinking through which level of care fits, contact our team.

Getting Started

Finding the right clinic is the first step, and it does not have to be the hardest one. If you or someone you love is managing a serious or complex mental health condition in the Triangle, Amae Health’s Raleigh clinic offers integrated care with psychiatry, therapy, group therapy, peer support, and health coaching under one team. Explore our full range of treatments, or call (984) 849-4342 to talk with our intake team about whether Amae is the right fit for your situation.

Frequently Asked Questions

–  What is the best mental health clinic in Raleigh, NC? There is no single best clinic; it depends on your condition, the support you need, and your insurance. For complex or serious conditions, Amae Health offers integrated psychiatric care. For broad access across the Triangle, Mindpath Health is a large network, and for therapy-focused care, Ellie Mental Health is a strong option.

–  What is the difference between psychiatry and behavioral health? Behavioral health is the broader term, covering mental health and substance use services. Psychiatry is a medical specialty within behavioral health focused on diagnosis and medication management. Both terms are used in Raleigh to describe outpatient mental health care.

–  Does NC Medicaid cover mental health treatment in Raleigh? Yes. NC Medicaid covers outpatient mental health services, including therapy and psychiatry. Several Raleigh clinics accept Medicaid managed-care plans like Alliance Health and Healthy Blue. Confirm network status with the clinic before booking.

–  What is outpatient behavioral health treatment? Outpatient treatment means receiving psychiatric care or therapy while living at home. It ranges from weekly sessions to intensive outpatient programs (IOP). Most people start with standard outpatient care and adjust based on need.

–  How long does it take to get a mental health appointment in Raleigh? It varies by provider. Some clinics offer same-day or same-week appointments, while academic centers may take longer. For free, 24/7 support, contact the 988 Suicide and Crisis Lifeline at 988 by call or text.

–  How much does therapy cost in Raleigh, NC? With insurance, in-network copays typically run $0 to $50 per session. Without insurance, therapy is usually $100 to $200 per visit and psychiatry $200 to $400. Some practices offer sliding-scale fees, so confirm costs with the clinic directly.

–  Can I get mental health treatment in Raleigh without insurance? Yes. Many Raleigh clinics offer sliding-scale fees, NC Medicaid is available to eligible residents, and Federally Qualified Health Centers in Wake County see patients regardless of ability to pay.

Citations

1. SAMHSA, National Substance Use and Mental Health Services Survey (N-SUMHSS) Definitions: “Partial hospitalization/day treatment.” info.nsumhss.samhsa.gov/definitions.htm. Tier 2 (U.S. government).

2. National Institute of Mental Health, “Psychotherapies.” nimh.nih.gov/health/topics/psychotherapies. Tier 2 (U.S. government).

3. Centers for Medicare & Medicaid Services, “The Mental Health Parity and Addiction Equity Act (MHPAEA).” cms.gov. Tier 2 (U.S. government).

‍

# min read

TMS vs. ECT: What Is the Difference and Who Are They For?

By

Sonia Garcia

|

September 28, 2026

TMS is not shock therapy. That is the first thing to settle in any TMS vs ECT comparison, because that phrase, and all the baggage that comes with it, refers to electroconvulsive therapy (ECT), not transcranial magnetic stimulation. TMS uses magnetic pulses, involves no anesthesia and no seizure, and you drive yourself home afterward. Both are evidence-based brain stimulation treatments for depression, and both work. They differ substantially in how they work, what the treatment is like to go through, and who they are typically used for. Knowing the difference between TMS and ECT is what lets you and your psychiatrist match the treatment to the situation.

What Is TMS?

Transcranial magnetic stimulation delivers focused magnetic pulses through a coil resting on the scalp to a specific region of the brain, usually the left dorsolateral prefrontal cortex, which is involved in mood regulation. The stimulation is targeted to that one site rather than generalized across the brain, and because it stimulates a small area without inducing a seizure, the procedure needs no anesthesia and takes place in an ordinary clinic or office, as the National Institute of Mental Health describes. FDA clearance came in 2008 for major depressive disorder, with obsessive-compulsive disorder added in 2018.

‍

At our clinics, a standard course of TMS therapy is 20 to 30 sessions, one per weekday, 30 to 40 minutes each, over about four to six weeks, and you sit awake in a chair for every one of them. No seizure is induced, nothing enters your bloodstream, and when the session ends you can drive yourself home and return to your day.

What Is ECT?

Electroconvulsive therapy is a controlled medical procedure performed under general anesthesia. You are given a short-acting anesthetic and an intravenous muscle relaxant to prevent movement, and electrodes on the scalp deliver a brief electrical current that produces seizure activity in the brain lasting under a minute. You wake within minutes, recover over the following hour or so, and need someone to take you home. A typical course is three sessions a week until symptoms improve, usually within 6 to 12 treatments.

‍

ECT is one of the oldest treatments in psychiatry and one of the most effective for severe depression. The FDA's clearance covers catatonia and severe depressive episodes in people age 13 and older with major depression or bipolar disorder who have not responded to other treatments or need a rapid response, and it is also used for mania and for certain presentations of schizophrenia and schizoaffective disorder. It is most often reserved for situations where fast, powerful relief matters: acute suicidality, depression with psychotic features, or catatonia.

‍

The stigma around ECT comes from portrayals that are decades out of date, from an era before anesthesia and muscle relaxants were used. Modern ECT is delivered in a monitored setting by a full medical team, and its main drawback is not what those old images suggest. It is the effect on memory, covered below.

TMS vs ECT: Side-by-Side Comparison

Feature TMS ECT
Setting Outpatient clinic or office Hospital or specialized clinic, in a monitored medical setting
Anesthesia None; you are awake General anesthesia plus a muscle relaxant
Mechanism Targeted magnetic pulses to the prefrontal cortex Electrical current producing a brief, controlled seizure
Session frequency and length Daily on weekdays, 30 to 40 minutes Typically three times a week; the seizure lasts under a minute, the visit takes longer with preparation and recovery
Course length 20 to 30 sessions over 4 to 6 weeks Usually 6 to 12 treatments over several weeks
Recovery time None; drive yourself home Grogginess and confusion afterward; someone must drive you home
Memory effects No known negative effect on memory or thinking Memory loss around the time of treatment, usually improving over the days and weeks after the course
Typical use Moderate or treatment-resistant depression without urgency Severe, urgent, psychotic, or catatonic presentations, or when other treatments have failed

Effectiveness: What the Research Shows

Both treatments work. In head-to-head trials of electroconvulsive therapy vs TMS, ECT comes out ahead. A 2014 systematic review and meta-analysis in Depression Research and Treatment pooled nine randomized clinical trials comparing the two, with 384 participants in total. Both groups improved significantly. On the Hamilton Depression Rating Scale, the standard clinician-rated measure, scores fell by an average of 15.4 points with ECT and 9.3 points with TMS, a statistically significant difference (P = 0.011). The author concluded that ECT produced larger reductions in depressive symptoms, while the results also supported the therapeutic validity of TMS for people with treatment-resistant depression.

‍

A few things keep that finding in proportion. The trials were conducted between 2000 and 2011, largely with early TMS protocols. And "more effective" is not the same as "the right choice." Real-world TMS outcomes come from a different population. In naturalistic data from 42 U.S. clinics, 58% of outpatients with medication-resistant depression responded to a standard course and 37% reached remission. For someone whose depression has resisted medication but who is stable enough for outpatient care, that is the relevant number.

‍

In the head-to-head studies that exist, ECT delivers stronger short-term symptom reduction. TMS delivers a meaningful effect without anesthesia, without a hospital, and without the recovery and memory considerations described next.

Side Effects and Memory Concerns

Memory is the question people bring to this comparison more than any other, and it deserves a direct answer.

‍

ECT is associated with memory effects, particularly for events around the time of treatment. NIMH describes memory loss close to the treatment period that is sometimes more severe but usually improves over the days and weeks after the course ends, alongside headaches, upset stomach, muscle aches, and short-lived confusion. The largest analysis of the question, a 2010 meta-analysis in Biological Psychiatry covering 84 studies and 2,981 patients, found that measurable cognitive effects were mainly limited to the first three days after treatment. By 4 to 15 days, nearly all measures had recovered, and after 15 days processing speed, working memory, new learning, and some aspects of executive function had improved beyond where they were before treatment, most likely because the depression itself had lifted. Some people do report longer-lasting gaps in personal memories from the months around treatment, and that possibility belongs in the conversation before ECT.

‍

TMS carries no known negative effect on memory or thinking, and it requires no anesthesia. Its side effects are local: discomfort where the coil sits, tingling or twitching of scalp or facial muscles during the pulses, mild headache, and occasional brief lightheadedness. Those usually fade within the first week. Seizure is the one serious risk, and it is exceedingly rare. Screening for seizure history, metal in the head, and implanted devices is what keeps it that way.

What to Expect: The Treatment Experience

The daily reality of the two treatments could not be more different.

‍

A TMS session is a 30-to-40-minute appointment. You sit in a chair, awake, while the coil delivers pulses that feel like tapping on the scalp. When it ends, you stand up, get in your car, and go on with your day, then repeat tomorrow. There is no downtime and no preparation beyond an initial screening visit.

‍

An ECT session is a medical procedure. You fast beforehand, an IV is placed, and you are under anesthesia for a few minutes while the treatment is delivered in a hospital or specialized clinic with an anesthesia provider and a psychiatrist present. You wake up groggy, spend time in recovery, and need someone to take you home. Over several sessions a week for several weeks, that is a real commitment from you and whoever supports you, and ECT is sometimes delivered during an inpatient stay rather than as an outpatient.

Who Is Each Treatment Typically Recommended For?

These are different tools for different clinical pictures, not simply a better and a worse option.

‍

ECT is typically recommended when depression is severe, acute, or urgent, and the speed of response matters: someone at high risk of suicide, someone with psychotic depression, someone with catatonia, or someone who has not responded to multiple treatments. The trade-off of anesthesia and memory effects is accepted because the alternative is worse, and for anyone in that situation care for suicidal thoughts comes first.

‍

TMS is typically recommended for moderate or treatment-resistant depression in someone who is stable enough for outpatient care and can attend daily sessions, when there is no need for the fastest possible response. It is often the next step after antidepressants have failed and before ECT would be considered. For that person, a treatment without anesthesia, without memory effects, and without disruption to work or family life has real value, even if its average effect size is smaller.

Talking to a Psychiatrist About Your Options

Choosing between TMS and ECT is a clinical decision, made with a psychiatrist, that turns on three things: how severe your depression is, how urgently it needs to change, and what you have already tried. It is not a decision to make from a comparison table alone, including this one.

‍

At Amae, we offer TMS at our Los Angeles, Los Altos, and San Mateo clinics as part of our integrated outpatient clinics, where psychiatry, therapy, primary care, and peer support come from one team. We do not offer ECT. If our psychiatrists conclude that ECT is the better clinical fit for you, they will say so and help coordinate a referral, because the goal is the right treatment, not the treatment we happen to provide. If you are trying to work out where you stand, talk with an Amae psychiatrist. And if you are having thoughts of suicide right now, call or text 988, the Suicide and Crisis Lifeline.

Frequently Asked Questions

Is TMS the same as ECT?

No, and it is not "shock therapy" either. That phrase refers to ECT. TMS uses magnetic pulses targeted to one region of the brain, with no anesthesia and no seizure, and you stay awake and drive yourself home. ECT uses electrical stimulation to produce a brief, controlled seizure under general anesthesia in a monitored medical setting.

Does TMS cause memory loss like ECT can?

No. TMS has no known negative effect on memory or thinking; its side effects are scalp discomfort and headache, both short-lived and usually gone within a week. ECT can cause memory loss around the time of treatment that typically improves over the weeks after the course ends.

Which is more effective, TMS or ECT?

In head-to-head research, ECT produces larger short-term symptom reductions. A 2014 meta-analysis of nine randomized trials found average Hamilton scale drops of 15.4 points with ECT versus 9.3 with TMS, with both treatments producing significant improvement. TMS remains a well-supported outpatient option without anesthesia or recovery time, so "more effective" is not the same as "right for your situation."

Is ECT still used today?

Yes. ECT remains a well-established, evidence-based treatment, typically used for severe, urgent, psychotic, or catatonic depression and for depression that has not responded to other treatments. The stigma around it comes from decades-old portrayals that do not resemble modern practice.

Can you drive yourself home after TMS or ECT?

After TMS, yes. There is no anesthesia or sedation, so people typically drive themselves home and return to their day immediately. After ECT, no. General anesthesia means you need a support person to take you home and some recovery time before normal activities.

Does Amae Health offer ECT?

No. We offer TMS at our Los Angeles, Los Altos, and San Mateo clinics as part of integrated psychiatric care. We do not offer ECT, and if a psychiatrist concludes that ECT is the better fit for your situation, we help coordinate a referral to a provider who does.

‍

Citations

  1. Micallef-Trigona B. Comparing the effects of repetitive transcranial magnetic stimulation and electroconvulsive therapy in the treatment of depression: a systematic review and meta-analysis. Depression Research and Treatment. 2014. https://pubmed.ncbi.nlm.nih.gov/25143831/ (Tier 1)
  2. National Institute of Mental Health. Brain Stimulation Therapies. https://www.nimh.nih.gov/health/topics/brain-stimulation-therapies/brain-stimulation-therapies (Tier 2)
  3. Semkovska M, McLoughlin DM. Objective cognitive performance associated with electroconvulsive therapy for depression: a systematic review and meta-analysis. Biological Psychiatry. 2010. https://pubmed.ncbi.nlm.nih.gov/20673880/ (Tier 1)
  4. Carpenter LL, Janicak PG, Aaronson ST, et al. Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of acute treatment outcomes in clinical practice. Depression and Anxiety. 2012. https://pubmed.ncbi.nlm.nih.gov/22689344/ (Tier 1)
  5. 988 Suicide and Crisis Lifeline. https://988lifeline.org (Tier 2)

‍